Page 148 - A Magyar Szemorvostársaság 2023. évi kongresszusa - Tudományos program és előadáskivonatok
P. 148

Objective:  The  aim  of  our  study  was  to  analyze  the  frequency  data  and  phenotypic
               characteristics of ABCA4 gene variants and to compare them with those previously described
               in scientific literature and by our Ophthalmic Genetics Unit.

               Methods: Our  study  included  diagnostic  genotyping  of more than  300  patients  with  retinal
               dystrophies  at  the  Ophthalmic  Genetics  Unit  of  Semmelweis  University's  Department  of
               Ophthalmology. Genetic testing was combined with both general as well as disease-specific
               ophthalmic and multimodal imaging & functional testing methods.

               Results: Among over 300 patients studied, different variants of the ABCA4 gene were detected
               in 70 cases that is nearly 1/4 of the patients. In terms of phenotypic appearance our team
               identified  Stargardt's  disease,  Fundus  Flavimaculatus  with  macular  dystrophy,  cone-rod
               dystrophy and retinitis pigmentosa. The study identified 13 cases of homozygous and 5 cases
               of heterozygous variants for the c.5917del, p.(Val1973*) variant, both leading to severe protein
               truncating lesions. The risk factor c.5603A>T, p.Asn1868Ile, known in the scientific literature
               as a risk factor, has been identified in 15 cases. In 21 cases, homozygous variations were
               detected, and the co-occurrence of 4 and 5 variants was also observed.


               Conclusions:  The  specific  mutational  mechanisms  indicate  the  severity  of  the  disease
               progression, meaning that the cases with multiple variants and certain types of abnormalities
               present a more severe phenotypic presentation from a younger age. Results of the studied
               cases  confirmed  the  heterogeneous  presentation  reported  in  the  literature,  with  the  risk
               increasing  hypomorphic  allele  also  modified  the  clinical  picture  in  a  manner  previously
               described by previous studies.

               The presentation will discuss both the genetic variants identified by our team and the research
               efforts to develop a therapeutic target for ABCA4 gene variations.
   143   144   145   146   147   148   149   150   151   152   153